Literature DB >> 30552737

Progression of retinitis pigmentosa on multimodal imaging: The PREP-1 study.

Mustafa Iftikhar1, Bushra Usmani1, Abanti Sanyal1, Saleema Kherani1, Simrat Sodhi1, Saghar Bagheri1, Etienne M Schönbach1, Nadia Junaid1, Hendrik P N Scholl1,2, Syed M A Shah1,3.   

Abstract

IMPORTANCE: It is important to establish reliable outcome measures to detect progression in retinitis pigmentosa (RP).
BACKGROUND: To evaluate progression of RP using multimodal imaging, including spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF) and microperimetry (MP).
DESIGN: Retrospective longitudinal study at a tertiary teaching hospital. PARTICIPANTS: 205 eyes of 106 patients with RP with 1 to 5 y of follow-up.
METHODS: Demographics and visual acuity (VA) were recorded, and each modality was graded at baseline and every annual follow-up. SD-OCT was graded for the width of ellipsoid zone (EZ), FAF was graded for the diameter and area of the hyperautofluorescent ring (if present), and MP was graded for mean, central and paracentral sensitivity. Spearman's correlation was used to measure correlations at baseline. Mixed effects models were used to estimate the annual change of each parameter, adjusted for disease duration. MAIN OUTCOME MEASURES: Rate of progression.
RESULTS: The median VA at baseline was 75 letters and was positively correlated with mean and central sensitivity (r: 0.372 and 0.394; P = 0.01 for both). All parameters (except paracentral sensitivity) were strongly correlated with each other (r: 0.673-0.991; P < 0.001 for all). The annual rates of change for each parameter were as follows: VA, -2.3 letters (P < 0.001); EZ, -151 μm (P < 0.001); ring diameter, -132 μm (P < 0.001); ring area, -0.4 mm2 (P < 0.001); mean sensitivity, -0.3 dB (P < 0.001); central sensitivity, -0.7 dB (P < 0.001); paracentral sensitivity, -0.4 dB (P < 0.001). CONCLUSIONS AND RELEVANCE: Structural and functional measures are well correlated in RP and can reliably measure disease progression within the course of a year.
© 2018 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  disease progression; fundus autofluorescence; microperimetry; multimodal imaging; optical coherence tomography

Year:  2019        PMID: 30552737     DOI: 10.1111/ceo.13458

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

Review 1.  Genetic, environmental and other risk factors for progression of retinitis pigmentosa.

Authors:  Zi-Yang Huang; Li-Na Liang; Ya-Min Li; Kai Xu; Xiao-Yu Li
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

2.  Association of retinal biomarkers and choroidal vascularity index on optical coherence tomography using binarization method in retinitis pigmentosa.

Authors:  Ebru N Cetin; Osman Parca; Hasan Samed Akkaya; Gökhan Pekel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-12       Impact factor: 3.117

3.  Blind patients in end-stage inherited retinal degeneration: multimodal imaging of candidates for artificial retinal prosthesis.

Authors:  Lorenzo Iuliano; Giovanni Fogliato; Eleonora Corbelli; Francesco Bandello; Marco Codenotti
Journal:  Eye (Lond)       Date:  2020-10-09       Impact factor: 3.775

Review 4.  The role of multimodal imaging and vision function testing in ABCA4-related retinopathies and their relevance to future therapeutic interventions.

Authors:  Saoud Al-Khuzaei; Mital Shah; Charlotte R Foster; Jing Yu; Suzanne Broadgate; Stephanie Halford; Susan M Downes
Journal:  Ther Adv Ophthalmol       Date:  2021-12-19

Review 5.  Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.

Authors:  Yesa Yang; Hannah Dunbar
Journal:  Ophthalmologica       Date:  2021-02-10       Impact factor: 3.250

6.  Test-retest variability of microperimetry in geographic atrophy.

Authors:  A Yasin Alibhai; Nihaal Mehta; Sheila Hickson-Curran; Carlos Moreira-Neto; Emily S Levine; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  Int J Retina Vitreous       Date:  2020-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.